A notable paradox emerges: Gal-9 is detected in T-cell tumor tissue in specific contexts (e.g., ATL), yet it also contributes to T-cell exhaustion or functional impairment in others (e.g., chronic viral infection or inflammatory skin disease). The gene discussed is LGALS9; the disease is inflammatory skin disease.